SNOA Sonoma Pharmaceuticals, Inc.

$1.31 +0.00%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

Sonoma Pharmaceuticals, Inc. (SNOA) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $6 million. Shares last traded at $1.31, 84.1% below their 52-week high. Over the past year the stock is down 56.5%. Net profit margin is -10.3%, below the peer median of -9.3%. Revenue grew 36.7% year over year.

Market Cap

$6M

Shares Out

4.8M

EPS (TTM)

$-3.49

P/E Ratio

—

P/S Ratio

0.29

P/B Ratio

0.95

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.22

52-Week Low

$0.88

Volume

1,767

Avg Vol (3m)

5,069.254

Performance

-2.24%

+15.93%

+10.08%

-53.21%

YTD

-63.66%

-56.48%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.87

SMA (50)

$1.25

SMA (200)

$2.25

Price vs SMA50

+4.92%

Price vs SMA200

-41.87%

ATR (14)

$0.05

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$22M

Net Income

$-2M

Gross Margin

38.9%

Operating Margin

-6.4%

Net Margin

-10.3%

Return on Equity

-34.3%

Return on Assets

-12.5%

Current Ratio

2.99

Debt / Equity

0.00

Revenue Growth (YoY)

+36.7%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q1 2027	$-0.09	2026-08-06
FY 2026	$-1.89	2026-06-16
Q3 2026	$-1.56	2026-02-10
Q2 2026	$-1.08	2025-11-04
Q1 2027	$-0.76	2026-08-06
FY 2026	$-2.79	2026-06-16

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

SNOA vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

0.29 / 2.94 med

-90% discount

Net margin vs peers

-10.3% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.